Advertisement

Dendritic Cells Have Reduced Cell Surface Membrane Glycoproteins Including CD43 Determinants

  • William Egner
  • Barry D. Hock
  • Derek N. J. Hart
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 329)

Abstract

The molecular basis for the special ability of dendritic cells (DC) to stimulate primary T cell responses is at present unknown. Important accessory molecules such as the adhesion molecules LFA-3, LFA-1, ICAM-1 and ICAM-2 and probably BB1/B7 (the ligand for T cell CD28 and CTLA-4) are expressed on DC1 and contribute to the antigen presenting function of DC. However no unique co-stimulatory cell membrane molecule or secreted cytokine has been identified on DC to date. Human blood, tonsil and bone marrow DC are potent stimulators of alloimmune T lymphocyte responses. Highly purified peripheral blood CD19 positive B cells and CD14 positive monocytes may also stimulate an alloresponse from peripheral blood T cells, including those carefully depleted of endogenous antigen presenting cells; albeit a less potent one.

Keywords

Peripheral Blood CD19 Neuraminic Acid Antigen Present Function Bone Marrow Dendritic Cell CD14 Positive Monocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. C. R. Prickett, J. L. McKenzie, and D. N. J. Hart, Adhesion molecules on human tonsil dendritic cells, Transplantation. 53: 483 (1992).PubMedCrossRefGoogle Scholar
  2. 2.
    K. Inaba, M. D. Witmer, and R. M. Steinman, Clustering of dendritic cells, helper T lymphocytes and histocompatible B cells during primary antibody responses in vitro, J. Exp. Med. 260: 858 (1984).CrossRefGoogle Scholar
  3. 3.
    D. N. J. Hart and J. L. McKenzie, Isolation and characterisation of human tonsil dendritic cells, J. Exp. Med. 168: 157 (1988).PubMedCrossRefGoogle Scholar
  4. 4.
    B. D. Hock and D. N. J. Hart, Cellular protein profiles of the Hodgkin’s disease cells lines L428, KM-H2 and HDLM-2: a comparative study, Leuk Res. 16: 253 (1992).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Stoll, R. Dalchau, and R. E. Schmidt, Cluster report: CD43, in Leucocyte Typing IV. White Cell Differentiation Antigens, W. Knapp, ed, Oxford University Press, Oxford (1989).Google Scholar
  6. 6.
    E. Remold-O’Donnell, C. Zimmerman, D. Kenney, and F. S. Rosen, Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome, Blood. 70: 104 (1987).PubMedGoogle Scholar
  7. 7.
    Y. J. Rosenstein, J. K. Park, W. C. Hahn, F. S. Rosen, B. E. Bierer, and S. J. Burakoff, CD43-a molecule defective in Wiskott-Aldrich syndrome binds ICAM-1, Nature. 354: 233 (1991).PubMedCrossRefGoogle Scholar
  8. 8.
    C. J. P. Boog, J. J. Neefjes, J. Boes, H. L. Ploegh and C. S. M. Melief, Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen presenting cells, Eur. J. Immunol. 19: 537 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • William Egner
    • 1
  • Barry D. Hock
    • 1
  • Derek N. J. Hart
    • 1
  1. 1.Haematology/Immunology Research GroupChristchurch School of Medicine Christchurch HospitalChristchurchNew Zealand

Personalised recommendations